Clinical trial
Imaging Immune Activation in HIV Infection
NCT03684655 is registered in ClinicalTrials.gov with CellSight Technologies, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Imaging Immune Activation in HIV Infection
- Lead sponsor
- CellSight Technologies, Inc.
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- September 21, 2018
- Completion date
- November 1, 2025
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.